Heiðar Ingi Ólafsson

Heiðar Ingi Ólafsson is the fund manager for Aldir, who recently became the chairman of the board for the biotechnology company Algalíf. He has expressed enthusiasm about expanding the company, noting significant market opportunities and a projected increase in revenue as they scale up production.